Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Vivo Ventures Fund Vi, L.p. Vivo Ventures Vi, Llc


  • Large Shareholder at Sagent Pharmaceuticals Inc. (SGNT), 2016-09-01
  • Large Shareholder at Eiger Biopharmaceuticals Inc. (EIGR), 2016-08-22
  • Large Shareholder at Carbylan Therapeutics Inc. (CBYL), 2015-04-24
  • Large Shareholder at Avanir Pharmaceuticals Inc. (AVNR), 2009-08-13
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AVNR $3.37 232,450 Large Shareholder 8,049,553 2009-08-11 Filing
AVNR $4.05 49,800 Large Shareholder 8,282,003 2009-08-11 Filing
AVNR $2.20 1,400 Large Shareholder 8,331,803 2009-07-31 Filing
AVNR $2.29 142,366 Large Shareholder 8,333,203 2009-07-30 Filing
AVNR $2.28 145,500 Large Shareholder 8,475,569 2009-07-29 Filing